Our Programme
| 11:30 – 12:30 | Registration and light lunch |
| 12:30 – 12:40 | Welcome & Introduction Speaker: Iryna Shakhnenko |
| 12:40 – 12:50 | Setting the scene Speaker: Winette van der Graaf |
| Session 1. INSIGHTS INTO CANCER BIOLOGY AND TREATMENT | |
| 12:50 – 13:10 | How cells become cancerous: how can causes become a path to the treatment? Speaker: Gianmarco Contino |
| 13:10 – 13:30 | Whole genome sequencing and implications of it Speaker: Celine Callens |
| 13:30 – 13:50 | Lifestyle driven cancers Speaker: Paul Nathan |
| 13:50 – 14:10 | Cancer care & research during the COVID-19 pandemics: lessons learned Speaker: Mieke Van Hemelrijck |
| 14:10 – 14:30 | QoL before, during, and after cancer treatments, incl. the impact of frailty and/or multiple conditions Speaker: Alexandra Gilbert |
| 14:30 – 14:50 | Q&A and panel discussion |
| 14:50 – 15:20 | Coffee break |
| Session 2. MULTIDISCIPLINARY TEAM MEETING | |
| 15:20 – 15:40 | Novel approaches in radiation oncology Speaker: Anna Kirby |
| 15:40 – 16:00 | Immunotherapy: who is eligible for it? Speaker: Kalijn Bol |
| 16:00 – 16:20 | Minimally invasive surgery: the role of robotics Speaker: Julien Van Damme |
| 16:20 – 16:40 | Break |
| Session 3. CLINICAL RESEARCH REGULATIONS | |
| 16:40 – 17:00 | The whole treatment development life cycle: the main stakeholders in clinical research and their challenges Speaker: Denis Lacombe |
| 17:00 – 17:15 | Key principles of the EU regulatory framework & role of regulators in the field of cancer clinical research Speaker: Giulia Gabrielli |
| 17:15 – 17:30 | Data altruism: myth or reality? Speaker: Teodora Lalova-Spinks |
| Session 4. CURRENT CHALLENGES OF PRODUCT DEVELOPMENT | |
| 17:30 – 17:50 | Medicines research and development Speaker: Pascale Cavillon |
| 17:50 – 18:05 | Precision and personalized medicine for cancer care Speaker: Abdelali Majdi |
| 18:05 – 18:20 | Marketing Authorization Holders point of view on current challenges in product development (Q&A and panel discussion) |
| As of 18:20 | Networking & reception dinner |
| 09:00 – 09:10 | Welcome & Introduction Speaker: Iryna Shakhnenko |
| Session 5. CLINICAL TRIALS | |
| 09:10 – 09:30 | Clinical trials: practical set-up, legal and ethical framework Speaker: Gaetan Schaetzen |
| 09:30 – 09:50 | Understanding objectives and endpoints in clinical cancer trials Speaker: Anne Giraut |
| 09:50 – 10:10 | Pragmatic trials and their value for patients Speaker: Robbe Saesen |
| 10:10 – 10:30 | Assessing patient needs in terms of research objectives and the relevance of endpoints Speaker: Winette van der Graaf |
| 10:30 – 10:50 | Randomisation, blinding, and placebo: what stands behind it Speaker: Saskia Litiere |
| 10:50 – 11:10 | Q&A and panel discussion |
| 11:10 – 11:50 | Coffee break |
| Session 6. REAL WORLD DATA & Artificial Intelligence | |
| 11:50 – 12:10 | RWD in cancer research: fundamentals Speaker: Jemma Boyle |
| 12:10 – 12:30 | AI in cancer diagnostics and treatment: its impact on future cancer research and outcomes Speaker: Andre Dekker |
| 12:30 – 12:50 | Q&A and panel discussion |
| 12:50 – 13:50 | Lunch break |
| Session 7. PATIENTS AND PATIENT INVOLVEMENT | |
| 13:50 – 14:10 | Patient involvement at EORTC Speaker: Iryna Shakhnenko |
| 14:10 – 14:30 | Diversity and inclusion: reducing inequality in patient involvement for people from different backgrounds Speaker: Katie Rizvi |
| 14:30 – 14:50 | Poll: Test your knowledge Facilitator: Iryna Shakhnenko |
| 14:50 – 15:20 | Patient testimonial Speaker: Ana Amariutei |
| 15:20 – 15:30 | Closing remarks |
| As of 15:30 | Drinks |
Our Programme
To view the full programme, please flip your phone horizontally:
